Medicinal Psilocybin in Utah

UT H.B. 167

Mental Illness Psychotherapy Drug Task Force

Utah HB 167, which passed the Utah House by a vote of 68 to 1 and the Utah Senate by a vote of 23 to 1 and has been signed by the Governer in March, will create a dedicated task force to research use of psilocybin to treat depression, post-traumatic stress disorder, anxiety, addiction and existential distress.

 

Potential Benefits of Medicinal Psilocybin

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur finibus sodales urna, vel ornare orci cursus sit amet. Vivamus condimentum risus faucibus felis aliquet ullamcor Praesent sapien massa, convallis a pellentesque nec, egestas non nisi.

Obsessive Compulsive Disorder

Studies have found the efficacy data provides sufficient scientific grounds to justify psilocybin as a treatment for OCD.
Source

Anxiety and Depression

Researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults.
Source

Addiction

Researchers showed longtime smokers who had failed many attempts to drop the habit did so after a carefully controlled and monitored use of psilocybin.
Source

What does HB 167 mean for Utah?

The bill wouldn’t legalize psilocybin which is designated as a Schedule I drug. The Bill  would authorize a task force to weigh the potential benefits with the potential dangers of legalization or decriminalization.

The group would meet and provide recommendations on:

  • specific types and symptoms of mental illness for which the psychotherapy drug could be used as a treatment option;
  • appropriate administration and dosage;
  • any license or credential requirement for individuals administering said drugs;
  • training that could be helpful for administers of the drug;
  • the frequency at which psychotherapy drug may be used;
  • any procedures to obtain, store, and monitor the use of the drugs;
  • safety requirements and procedures for data tracking, and more.

    HB 167 36-29-303. Duties

 

Psychotherapy Drug Task Force

The task force consists of experts in fields of psychiatry, psychology, pharmacology, neuroscience, mental health, trauma focused therapy, and addiction medicine.  It  also includes representatives from Utah Medical Association, a Utah hospital, and patient advocacy groups. 

Supporting Medical Research

Medical Psilocybin Publications and Resources

 

Johns Hopkins Medicine

Psychedelics Research and Psilocybin Therapy

ACS

Psilocybin Therapeutic Research: The Present and Future Paradigm

The Mental Health Clinician

Clinical potential of psilocybin as a treatment for mental health conditions

How Can I Get Involved?

We are so glad you asked. 

Join Us

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur finibus sodales urna, vel ornare orci cursus sit amet. Vivamus condimentum risus faucibus felis aliquet ullamcor Praesent sapien massa, convallis a pellentesque nec, egestas non nisi.

Donate

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur finibus sodales urna, vel ornare orci cursus sit amet. Vivamus condimentum risus faucibus felis aliquet ullamcor Praesent sapien massa, convallis a pellentesque nec, egestas non nisi.

Mankind’s History  of Psychedelics 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur finibus sodales urna, vel ornare orci cursus sit amet. Vivamus condimentum risus faucibus felis aliquet ullamcorper. Nulla condimentum, odio sit amet ullamcorper pretium, purus orci faucibus tortor, non suscipit lectus lorem at dolor. Aliquam rhoncus malesuada tortor